These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 15628198)

  • 1. The economics of vaccination in low- and middle-income countries.
    Fox-Rushby JA; Kaddar M; Levine R; Brenzel L
    Bull World Health Organ; 2004 Sep; 82(9):640. PubMed ID: 15628198
    [No Abstract]   [Full Text] [Related]  

  • 2. Economics of polio vaccination in the post-eradication era: should OPV-using countries adopt IPV?
    Khan MM
    Vaccine; 2008 Apr; 26(16):2034-40. PubMed ID: 18339460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicine. The intangible value of vaccination.
    Rappuoli R; Miller HI; Falkow S
    Science; 2002 Aug; 297(5583):937-9. PubMed ID: 12169712
    [No Abstract]   [Full Text] [Related]  

  • 4. Rotavirus vaccination: cost-effectiveness and impact on child mortality in developing countries.
    Atherly D; Dreibelbis R; Parashar UD; Levin C; Wecker J; Rheingans RD
    J Infect Dis; 2009 Nov; 200 Suppl 1():S28-38. PubMed ID: 19817610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries.
    Rheingans RD; Antil L; Dreibelbis R; Podewils LJ; Bresee JS; Parashar UD
    J Infect Dis; 2009 Nov; 200 Suppl 1():S16-27. PubMed ID: 19817595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Projected cost-effectiveness of rotavirus vaccination for children in Asia.
    Podewils LJ; Antil L; Hummelman E; Bresee J; Parashar UD; Rheingans R
    J Infect Dis; 2005 Sep; 192 Suppl 1():S133-45. PubMed ID: 16088797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Decision regarding vaccination].
    Lévy-Bruhl D
    Rev Epidemiol Sante Publique; 1995; 43(1):5-6. PubMed ID: 7892517
    [No Abstract]   [Full Text] [Related]  

  • 8. [What is the cost of health in low income countries].
    Pulcinelli C
    Assist Inferm Ric; 2006; 25(3):189-90. PubMed ID: 17080629
    [No Abstract]   [Full Text] [Related]  

  • 9. The Breast Health Global Initiative: clinical practice guidelines for management of breast cancer in low- and middle-income countries.
    Yip CH; Anderson BO
    Expert Rev Anticancer Ther; 2007 Aug; 7(8):1095-104. PubMed ID: 18028018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eradication versus control: the economics of global infectious disease policies.
    Barrett S
    Bull World Health Organ; 2004 Sep; 82(9):683-8. PubMed ID: 15628206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-benefit comparisons of investments in improved water supply and cholera vaccination programs.
    Jeuland M; Whittington D
    Vaccine; 2009 May; 27(23):3109-20. PubMed ID: 19428925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications.
    Goldie SJ; O'Shea M; Diaz M; Kim SY
    Reprod Health Matters; 2008 Nov; 16(32):86-96. PubMed ID: 19027626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Childhood disability in low- and middle-income countries: overview of screening, prevention, services, legislation, and epidemiology.
    Maulik PK; Darmstadt GL
    Pediatrics; 2007 Jul; 120 Suppl 1():S1-55. PubMed ID: 17603094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Policy evaluation for the subsidy for influenza vaccination in elderly.
    Ohkusa Y
    Vaccine; 2005 Mar; 23(17-18):2256-60. PubMed ID: 15755606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A real shot.
    Diamond B
    Nat Med; 2005 Apr; 11(4 Suppl):S3-4. PubMed ID: 15812487
    [No Abstract]   [Full Text] [Related]  

  • 16. Investors, HMOs, policy makers see value in vaccines.
    Fox JL
    Nat Biotechnol; 1996 Dec; 14(13):1646-7. PubMed ID: 9634838
    [No Abstract]   [Full Text] [Related]  

  • 17. Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam.
    Fischer TK; Anh DD; Antil L; Cat ND; Kilgore PE; Thiem VD; Rheingans R; Tho le H; Glass RI; Bresee JS
    J Infect Dis; 2005 Nov; 192(10):1720-6. PubMed ID: 16235169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost-effectiveness of typhoid Vi vaccination programs: calculations for four urban sites in four Asian countries.
    Cook J; Jeuland M; Whittington D; Poulos C; Clemens J; Sur D; Anh DD; Agtini M; Bhutta Z;
    Vaccine; 2008 Nov; 26(50):6305-16. PubMed ID: 18835415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surgery is needed in low and middle income countries. Highly cost-effective public health intervention].
    von Schreeb J
    Lakartidningen; 2012 Jan 18-24; 109(3):86. PubMed ID: 22448558
    [No Abstract]   [Full Text] [Related]  

  • 20. Global rotavirus surveillance: determining the need and measuring the impact of rotavirus vaccines.
    Widdowson MA; Steele D; Vojdani J; Wecker J; Parashar U
    J Infect Dis; 2009 Nov; 200 Suppl 1():S1-8. PubMed ID: 19817589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.